NEW YORK (Reuters)—The U.S. hospital and health insurance industries breathed a collective sigh of relief on Thursday after the U.S. Supreme Court upheld subsidies for individuals under President Barack Obama’s signature healthcare law. Shares in hospitals surged, with several hitting all-time highs, on the expectation that patients would be able to continue paying for services….
Search results for: hospital
Many U.S. Hospitals Mark Up Prices 1,000%
NEW YORK (Reuters)—Even the astronomical price markups that consumers regularly pay for, say, wine in restaurants pale beside those in some U.S. hospitals: The price for procedures is often 10 times the cost, according to a study published Monday in the journal Health Affairs. Of the 50 hospitals with the highest markups, 49 are for-profit,…
Ethics Forum: Terminating Hospital Consulting Services
Ethical considerations for rheumatologists in terminating consultative services to a community hospital
Selling a Rheumatology Practice to a Hospital or Health System
Negotiating points, key business decisions to consider when transferring ownership
Backlog Slows Medicare Appeals Process for Hospitals, Physicians
Recovery Audit Program brings in record number of appeals, clogs system
Hospitalists Gain Insight on Signs, Symptoms of Infection Among Inpatients on Biologic Drugs
Rheumatologist at Society of Hospital Medicine conference provides treatment recommendations for hospital patients with rheumatic disease
Shingles, Chickenpox Hospitalizations Higher for Patients on Anti-TNF Drugs
More research needed to clarify risks and benefits of VZV vaccination
Studies Show High-Intensity Interval Training Lowers Inflammatory Disease Activity
Experts discuss HIIT as an underused ‘disease-modifying drug’ for inflammatory diseases. Learn how to safely integrate it into patient treatment plans.
Calcium Pyrophospate Deposition Disease Diagnosis & Treatment Gaps Remain
CPPD diagnosis is difficult & treatments are limited. Experts review radiology challenges, off-label options like colchicine, & emerging biologics.
Balancing Optimism & Skepticism in CAR T for SLE
At ACR Convergence 2025, Joan T. Merrill, MD, overviewed the current research landscape of chimeric antigen receptor (CAR) T cell therapies for systemic lupus erythematosus (SLE), raising important scientific questions about these emerging treatments.
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 328
- Next Page »